Ferritin in the cerebrospinal fluid of patients with Parkinson's disease Transition metal ions, particularly iron, copper and manganese are capable of producing oxygen-containing free radicals' which have the potential for causing tissue damage. The normal brain contains large concentrations of copper and iron, located in large part within the basal ganglia.' The biochemical forms and physiological functions of these metal ion deposits are largely unknown. We have previously reported finding elevated copper ion concentrations and normal total iron concentrations in the cerebrospinal fluid (CSF) of patients with untreated, idiopathic Parkinson's disease (PD).4 Others have found increased total iron concentrations in the zona compacta of post mortem substantia nigra from patients with PD.' Iron in a nonprotein-incorporated state is potentially cytotoxic.' In tissues it is probably stored in an inert form within the protein, ferritin.6 We have measured the concentration of ferritin in the CSF and serum of patients with PD and a control group. Informed consent for undergoing a lumbar puncture to obtain CSF was obtained from patients with untreated, idiopathic PD. These patients were aware that the test was being done for research purposes before, after one hour and at the end of the infusion, then at four and six hours after the infusion, and every morning at 9 am until the next infusion. All hormones were measured as previously described,' except that prolactin standards were obtained from the Division ofMolecular Endocrinology, Hammersmith Hospital, London. The detection limit for prolactin was 40 mU/l. Results were analysed using analysis of variance with Duncan's test for multiple comparisons. Correlations between groups were described using Spearman's test. The study was approved by the local ethics committee. Each time point has been ascribed a number in the order in which blood samples were taken, and is identified by this number in the graphs (fig) . Samples were taken during and immediately after the infusions more rapidly than at other times, and thus the time scale of the points in the graph is not constant.
The first infusion caused a significantly grester TSH response than the subsequent infusions, each of which caused a response similar to each other. The basal trough levels of TSH between infusions were significantly lower than the TSH concentration before the first infusion, despite the fact that trough T4
and T3 concentrations were not significantly different from pre-treatment levels.
The marked prolactin response to each infusion was similar, and trough levels of prolactin were no different to pre-treatment levels.
The thyroid hormone responses to RX77368 reflect the TSH response. 
